FDA approves Glenmark's generic of antipsychotic Lithobid - Related Stories - AANP SmartBrief
Links shared publicly online about this topic.
- 619total visits
FDA approves Glenmark's generic of antipsychotic Lithobid - Related Stories - AANP SmartBrief
Glenmark Generics received marketing approval from the FDA for a 300-milligram tablet of extended-release lithium carbonate. The product, a copy of Noven Therapeutics' Lithobid, is used for treating manic episodes associated with bipolar disorder.
View full resource at smartbrief.com
Tags: Bipolar Disorder, Bipolar Disorder Medication, FDA, Eskalith, Nursing Professions, Nurse, Nursing
Most Recently Shared on December 29, 2010 at 4:13 pm By:
FDA approves Glenmark's #generic of #antipsychotic Lithobid http://sbne.ws/r/6p4p #mentalhealth #nurse
Advertisement
